| Financial Year |
March 31 2023 |
| Monetary Funds |
326,265,031.85 |
| Held-for-trading Financial Assets |
210,000.00 |
| Notes Receivable |
205,040,985.83 |
| Accounts Receivable |
69,882,933.64 |
| Advances to Suppliers |
53,444,919.69 |
| Other Receivables |
67,023,738.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,579,375,380.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
188,506,624.07 |
| Total Current Assets |
2,514,347,618.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
179,576.86 |
| Long-term Equity Investment |
28,063,408.94 |
| Investment Properties |
67,818,072.87 |
| Fixed Assetes |
1,739,597,089.43 |
| Under-construction Projects |
7,164,248,099.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,849,605,318.69 |
| R&D expenses |
-- |
| Goodwill |
103,547,921.42 |
| Long-Term Deferred and Prepaid Expenses |
10,997,857.45 |
| Deferred Income Tax Assets |
160,148,423.67 |
| Other Non-Current Assets |
226,843,225.01 |
| Sub-Total of Non-Current Assets |
11,369,957,021.68 |
| Total Assets |
13,884,304,640.30 |
| Short-Term Loans |
358,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,000,000.00 |
| Accounts Payable |
1,557,198,258.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,933,573.35 |
| Taxes Payable |
130,492,790.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
912,880,422.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
628,456,332.17 |
| Other Current Liabilities |
217,944,445.49 |
| Sub-Total of Current Liabilities |
4,131,886,000.15 |
| Long-term Loans |
477,534,268.00 |
| Bonds Payable |
112,743,003.43 |
| Long-Term Accounts Payable |
492,321,428.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
22,549,868.00 |
| Deferred Income Tax Liabilities |
111,465,946.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,346,642,019.54 |
| Total Liabilities |
5,478,528,019.69 |
| Paid-In Capital(Or Share Stock) |
1,915,664,539.00 |
| Capital Surplus |
4,176,939,613.31 |
| Surplus Reserve |
180,099,386.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,447,964,086.57 |
| Minority Stockholder's Interest |
653,510,061.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,752,266,559.56 |
| Owner's Equity（Stockholder's Equity） |
8,405,776,620.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,884,304,640.30 |
